Merck Announces Positive Phase 3 Results for Endometrial Cancer Drug HarianBasis.co
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial MSN
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints Yahoo Finance
The establishment of a successful pregnancy depends on proper embryo development and coordinated endometrial differentiation, particularly through the process of decidualization. Mesenchymal stem/stromal cells (MSCs), especially those derived from endometrial …
Endometriosis-associated pelvic pain represents a prototypical failure of systemic therapy for a locally organized, neuroinflammatory disease. Persistent pain arises from the convergence of estrogen-driven lesion survival, chronic inflammation, fibrosis, and …
Endometrial Serous Carcinoma Arising From Adenomyosis Cureus
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Estrogen stimulates corticotropin-releasing hormone (CRH) expression in endometrial tissue, and CRH signaling contributes to inflammation and pain, suggesting a mechanistic role in endometriosis pathophysiology. We previously identified elevated CRH receptor-1 …